IRIS
CALABRESE, EMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.336
AS - Asia 5.705
EU - Europa 3.592
SA - Sud America 644
AF - Africa 72
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 39.361
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 29.228
SG - Singapore 3.677
CN - Cina 797
IT - Italia 735
BR - Brasile 551
RU - Federazione Russa 475
DE - Germania 448
HK - Hong Kong 367
UA - Ucraina 364
IE - Irlanda 351
VN - Vietnam 333
SE - Svezia 281
FR - Francia 258
FI - Finlandia 221
GB - Regno Unito 174
BD - Bangladesh 119
JP - Giappone 106
KR - Corea 80
IN - India 67
NL - Olanda 56
CA - Canada 55
PL - Polonia 50
BE - Belgio 45
AR - Argentina 29
CZ - Repubblica Ceca 29
EC - Ecuador 28
TR - Turchia 28
MX - Messico 25
ZA - Sudafrica 25
AT - Austria 24
ES - Italia 24
IQ - Iraq 23
ID - Indonesia 13
MA - Marocco 12
VE - Venezuela 12
DK - Danimarca 11
PH - Filippine 11
PK - Pakistan 10
UZ - Uzbekistan 10
EG - Egitto 9
GR - Grecia 8
TN - Tunisia 8
CL - Cile 7
EU - Europa 7
PY - Paraguay 7
TH - Thailandia 7
IL - Israele 6
KG - Kirghizistan 6
PE - Perù 6
CH - Svizzera 5
JM - Giamaica 5
JO - Giordania 5
RO - Romania 5
SA - Arabia Saudita 5
CR - Costa Rica 4
DZ - Algeria 4
HR - Croazia 4
LT - Lituania 4
SV - El Salvador 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
BG - Bulgaria 3
IR - Iran 3
KE - Kenya 3
NP - Nepal 3
PS - Palestinian Territory 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CO - Colombia 2
CY - Cipro 2
DM - Dominica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GA - Gabon 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
AO - Angola 1
BB - Barbados 1
BS - Bahamas 1
EE - Estonia 1
GE - Georgia 1
GY - Guiana 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 39.348
Salva come PNG Salva come JPEG
Città #
Woodbridge 7.909
Houston 6.651
Wilmington 6.631
Singapore 1.049
Fairfield 924
Ann Arbor 833
Ashburn 606
San Jose 506
Chandler 463
Seattle 415
Hong Kong 363
Cambridge 328
Jacksonville 318
Dublin 317
Dallas 299
Beijing 268
Medford 235
Rome 226
Santa Clara 188
Dearborn 184
New York 168
The Dalles 161
Council Bluffs 139
Los Angeles 131
Helsinki 127
Lawrence 110
Ho Chi Minh City 99
Tokyo 92
Zhengzhou 81
Lauterbourg 75
Hanoi 68
Buffalo 67
Moscow 65
San Diego 64
Milan 56
Munich 51
Brussels 45
Menlo Park 40
São Paulo 40
North Bergen 39
Mülheim 35
Orem 32
Shanghai 30
Boardman 28
Rio de Janeiro 27
London 26
Nuremberg 26
Chicago 25
Kraków 24
Redondo Beach 24
Atlanta 22
Chennai 22
Columbus 21
Redwood City 21
Norwalk 20
Warsaw 19
Belo Horizonte 18
Frankfurt am Main 18
Amsterdam 17
Lappeenranta 17
Brno 16
Brooklyn 16
Nanjing 16
Verona 16
Denver 15
North Charleston 15
Palo Alto 15
Toronto 15
Naples 14
Quito 14
Phoenix 13
University Park 13
Vienna 13
Haiphong 12
Hefei 12
Baghdad 11
Florence 11
Johannesburg 11
Montreal 11
San Francisco 11
Seoul 11
Bologna 10
Boston 10
Charlotte 10
Colorado Springs 10
Da Nang 10
Indianapolis 10
Jakarta 10
Kilburn 10
Kunming 10
Mountain View 10
Olomouc 10
Philadelphia 10
Brasília 9
Cedarhurst 9
Manchester 9
Poplar 9
San Mateo 9
Stockholm 9
Ankara 8
Totale 31.366
Salva come PNG Salva come JPEG
Nome #
Unrelated cord blood transplant in children with high-risk acute lymphoblastic leukemia: a long-term follow-up 686
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. 616
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 609
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study 609
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. 594
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 577
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While heal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study 564
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 557
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis? 548
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 537
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 533
Ultrasound of the small bowel in Crohn's disease 532
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 522
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 514
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study 513
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 509
Local injection of infliximab in the postoperative recurrence of Crohn's disease 502
Cancer and immunomodulators in inflammatory bowel diseases 500
A family study of asymptomatic small bowel Crohn's disease 495
Infliximab and newly diagnosed neoplasia in Crohn's disease: A multicentre matched pair study 486
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study 479
Surgery for fistula-in-ano in a specialist colorectal unit: a critical appraisal 479
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia 477
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 477
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 477
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study 470
Planck 2013 results. I. Overview of products and scientific results 470
Accuracy of Small Intestine Contrast Ultrasonography, Compared to Computed Tomography Enteroclysis, in Characterizing Lesions in Patients with Crohn's Disease. 466
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: A novel recognizable microdeletion syndrome? 464
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 460
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and after Ileocolonic Resection. 459
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study 456
Planck 2013 results. XV. CMB power spectra and likelihood 456
Measuring disease activity in Crohn's disease 455
Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study. 452
Antisense approach to inflammatory bowel disease: Prospects and challenges 452
Ultrasound in Crohns Disease 451
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 446
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 446
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. 443
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 443
Is It Always Necessary to Treat CD Patients? 437
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 437
Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease 437
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 435
1 435
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 434
Treatment with biologic therapies and the risk of cancer in patients with IBD. 432
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 430
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn's Disease After Resection Different from Ileo-Colonic 428
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. 425
A Sonographic Lesion Index for Crohn's Disease Helps Monitor Changes in Transmural Bowel Damage During Therapy 425
Planck 2013 results. XXII. Constraints on inflation 420
Malattia di Crohn. In: Malattie del canale digerente. Gasbarrini G, Morelli A. 417
Capsule endoscopy and proximal small bowel lesions in patients with Crohn’s disease. 414
null 409
Comparison between techniques providing the luminal vs extraluminal surface in assessing Crohn’s disease recurrance: a prospective longitudinal study. 406
Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis 403
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 400
Laparoscopic versus open ileo-colonic resection in Crohn's disease: short- and long-term results from a prospective longitudinal study 397
Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease 391
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case–control IG-IBD study 390
Cancer in Infliximab treated or untreated Crohn’s disease patients: a 2 years longer follow up from a multicenter matched-pair study.. 378
New biologic therapies in patients with Inflammatory Bowel Disease [Nuovi farmaci biologici nelle Malattie Infiammatorie Croniche Intestinali] 377
Severity of Crohn’s disease recurrence after ileo-colon resection: correlation between endoscopic score and sonographic findings. 375
Ileal lesions in patients with Ulcerative Colitis after ileo-rectal anastomosis: relationship with colonic metaplasia. 367
Assessment of Crohn’s disease recurrence after Ileo-colonic resection: correlation between endoscopic score and sonographic findings. 362
Severity of postoperative recurrence in Crohn's disease: correlation between endoscopic and sonographic findings 355
Endoscopic vs ultrasonographic findings related to Crohn's disease recurrence: a prospective longitudinal study at 3 years. 352
Newly diagnosed neoplasia in a cohort of Crohn’s disease patients treated with Infliximab: a 3 years longer follow up from a multicenter matched-pair study. 337
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab 308
Malattia di Crohn. In: Malattie del canale digerente 303
Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach 272
The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies 258
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 256
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 232
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 216
EFSUMB Recommendations and Guidelines for Gastrointestinal Ultrasound 214
Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts. 188
ECCO-ESGAR guideline for diagnostic assessment in ibd part 2: Ibd scores and general principles and technical aspects 184
Hepatic follicular lymphoma in an old patient with Crohn’s disease: a rare case and review of the literature 181
Fecal and mucosal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease 175
Real-time Interobserver Agreement in Bowel Ultrasonography for Diagnostic Assessment in Patients With Crohn's Disease: An International Multicenter Study. 170
Prospective observational study on the evaluation of quality of life in patients affected by enteropathic spondyloarthritis 155
The impact of COVID-19 pandemic in the colorectal cancer prevention 141
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 140
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 135
Mucinous and Signet-Ring Cell Colonic Adenocarcinoma in Inflammatory Bowel Disease: A Case-Control Study 126
Post-operative recurrence of Crohn's disease: A prospective study at 5 years 122
Ultrasonography tight control and monitoring in Crohn's disease during different biological therapies: a multicenter study 119
Crohn's disease: A comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema 108
Impact of biological therapy in reducing the risk of arthritis development in inflammatory bowel diseases 107
Treatment with biologic therapies and the risk of cancer in patients with IBD 101
Concept design of the LiteBIRD satellite for CMB B-mode polarization 100
Efficacy and tolerability of very low-volume bowel preparation in patients with inflammatory bowel diseases 98
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 97
Onset of ulcerative colitis during SARS-Cov-2 infection 95
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 94
Response assessed by ultrasonography as target of biological treatment for Crohn's disease 94
EFSUMB Recommendations and Clinical Guidelines for Intestinal Ultrasound (GIUS) in Inflammatory Bowel Diseases 92
Totale 37.267
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.192
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202184 0 0 0 0 0 0 0 0 0 0 0 84
2021/20221.406 54 143 72 118 81 102 69 71 213 115 64 304
2022/20231.291 159 94 21 162 121 329 119 65 108 7 72 34
2023/2024523 56 16 34 16 63 127 38 48 5 22 7 91
2024/20254.924 90 721 373 211 79 252 250 118 426 236 1.232 936
2025/20265.592 398 256 793 461 391 196 699 699 607 508 305 279
Totale 39.935